Luma Vision announced that it completed 15 AFib ablation procedures as part of a clinical study in collaboration with CardioFocus.

Partnership expands access to clinically proven esophageal protection for atrial fibrillation ablation across federal ...

In recent days, Boston Scientific has drawn upbeat commentary from Wall Street, with analysts citing strong demand across ...

While I believe Pfizer will rebound eventually, it will take some time to do so, and it may not occur in 2026. In the ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond ...

As more patients seek lasting, tech-forward solutions to tooth loss, the practice adapts with expanded implant services ...

Preliminary results from the FULCRUM-VT trial point to a safer, more effective way to treat ventricular tachycardia—a dangerous heart rhythm disorder that can lead to sudden cardiac arrest.